| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 28 | 2 | 2005 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2012 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2002 | 2019 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1995 | 2020 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1987 | 2018 | ||||||||
|
histone deacetylase 6 | 0.465 | 0.846 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2018 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2006 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.040 | None | 0.750 | 4 | 1 | 2000 | 2016 | ||||||||
|
nuclear factor kappa B subunit 2 | 0.509 | 0.808 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1994 | 2010 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1998 | 2019 | ||||||||
|
EPH receptor A7 | 0.619 | 0.500 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2013 | ||||||||
|
lysine methyltransferase 2D | 0.465 | 0.808 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2018 | ||||||||
|
transformation/transcription domain associated protein | 0.572 | 0.692 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2018 | ||||||||
|
CREB binding protein | 0.428 | 0.808 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2019 | ||||||||
|
fms related receptor tyrosine kinase 4 | 0.457 | 0.808 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2017 | ||||||||
|
bromodomain containing 4 | 0.446 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2020 | ||||||||
|
RPTOR independent companion of MTOR complex 2 | 0.592 | 0.615 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2020 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2010 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2014 | ||||||||
|
notch receptor 2 | 0.441 | 0.808 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2014 | ||||||||
|
BCL6 corepressor | 0.471 | 0.808 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2017 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2018 | ||||||||
|
SOS Ras/Rac guanine nucleotide exchange factor 1 | 0.485 | 0.808 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2013 | ||||||||
|
lysine demethylase 6A | 0.498 | 0.769 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 |